Back to Screener

Healthcare

bioMérieux S.A.(BMXMF)

Live Price

Offline

$78.00

+0.00% today

1Y Change

-45.24%

Window

Jun 26, 2025 → Jun 24, 2026

Market Cap
$8.26B
Revenue Growth
+2.2%
EPS Growth
-8.2%
Dividend Yield
1.3%

Coverage: 249 bars · Jun 26, 2025 → Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

bioMérieux S.A. (BMXMF) is a Healthcare stock with a market cap of $8.26B. The stock last traded around $78.00 and down 45.2% across the available one-year price window (Jun 26, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of +2.2%, EPS growth of -8.2%, a dividend yield of 1.3%. What stands out right now is revenue +2.2%, EPS -8.2%, free cash flow +40.8% with operating margin 9.5% and ROIC 6.3%. The dividend is present but secondary, with a yield around 1.3%. Valuation is more restrained than many high-expectation growth names at P/E 20.8 and price/sales 2.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BMXMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BMXMF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BMXMF

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BMXMF Max Drawdown

-49.13%

Trailing 1Y

SPY Max Drawdown

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BMXMF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

📅 Next earningsJul 28, 2026
PeriodB/MEPSEPS ΔRevenueRev ΔReport
Jul 28, 26
TBD
Est
Est 1165621.0B
Jul 28
Feb 27, 26
2.35
Est 2.50
-6.0%
2379557.0B
Est 2489961.0B
-4.4%
Feb 27
Jun 30, 25
1.59
Est 2.55
-37.6%
2406451.9B
Est 2440206.3B
-1.4%
Jun 30
Dec 31, 24
1.89
Est 2.23
-15.3%
2151748.2B
Est 2127687.7B
+1.1%
Dec 31
Jun 29, 24
1.95
Est
2044999.0B
Est 2009421.1B
+1.8%
Jun 29
Dec 30, 23
1.81
Est
2094600.2B
Est
Dec 30
Jun 30, 23
1.49
Est
1931016.8B
Est
Jun 30
Dec 31, 22
2.04
Est
2080119.8B
Est
Dec 31
Jun 30, 22
2.01
Est
1734300.6B
Est
Jun 30
Dec 31, 21
3.08
Est 1.91
+61.3%
2042946.5B
Est 1806462.0B
+13.1%
Dec 31
Jun 30, 21
2.77
Est 2.22
+24.8%
1867699.1B
Est 1704376.3B
+9.6%
Jun 30
Dec 31, 20
2.39
Est 1.70
+40.6%
2013695.4B
Est 1824068.2B
+10.4%
Dec 31
Jun 30, 20
1.64
Est 1.81
-9.4%
1661048.5B
Est 1750654.0B
-5.1%
Jun 30
Dec 31, 19
1.27
Est 1.36
-6.6%
1588105.2B
Est 1567570.5B
+1.3%
Dec 31
Jun 30, 19
1.34
Est
1447853.5B
Est
Jun 30
Dec 31, 18
1.24
Est
1496139.5B
Est
Dec 31
Jun 30, 18
1.32
Est
1357239.9B
Est
Jun 30
Dec 31, 17
1.35
Est
1353881.1B
Est
Dec 31
Jun 30, 17
0.98
Est
1292603.9B
Est
Jun 30
Dec 31, 16
0.83
Est
1156349.3B
Est
Dec 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.